Almirall has completed the decentralised regulatory procedure in Europe for efinaconazole to treat onychomycosis.

Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology announced today the successful ...

Jublia (efinaconazole), and Kerydin (tavaborole) Laser therapy Paronychia is an infection of the skin surrounding the nail ...

at 02:35 Almirall Announces Completion of Decentralized Regulatory Approval Procedure for Efinaconazole in Europe Almirall, S ...

Efinaconazole is a triazole antifungal compound indicated for the treatment of onychomycosis, a persistent and difficult to treat fungal infection of the nail The completion of the decentralized ...

The low binding affinity of efinaconazole topical to keratin, the main component of nails, allows high nail-penetrating properties supporting strong efficacy. With the addition of this treatment ...

S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology announced today the successful completion of the decentralized regulatory procedure in Europe for efinaconazole ...